ELI LILLY & Co — Director's Dealing 2019

May 3, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2019-05-01

Reporting Person: Shaw Christi (SVP and Pres., Lilly Bio-Meds)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-05-01	Common Stock	M	13750	—	Acquired	13750	Direct
2019-05-01	Common Stock	F	6173	$117.04	Disposed	7577	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-05-01	Restricted Stock Unit	$	M	13750	Disposed	2019-05-01	Common Stock (13750.0)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.

F2: The restricted stock units vested in two equal installments on May 1, 2018 and May 1, 2019.